Risk factors for Coronavirus disease-associated mucormycosis

[1]  Shruti Kochar Maru,et al.  Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1 , 2021, Indian journal of ophthalmology.

[2]  S. Bhadada,et al.  Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India , 2021, Postgraduate Medical Journal.

[3]  S. Rudramurthy,et al.  Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India , 2021, Emerging infectious diseases.

[4]  S. Corrao,et al.  Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc , 2021, Nutrients.

[5]  J. Schultze,et al.  Neutrophils in COVID-19 , 2021, Frontiers in Immunology.

[6]  G. Duan,et al.  Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches , 2020, Signal Transduction and Targeted Therapy.

[7]  A. Chughtai,et al.  Last-resort strategies during mask shortages: optimal design features of cloth masks and decontamination of disposable masks during the COVID-19 pandemic , 2020, BMJ open respiratory research.

[8]  N. Oliver,et al.  New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K. , 2020, Diabetes Care.

[9]  A. Scarano,et al.  Facial Skin Temperature and Discomfort When Wearing Protective Face Masks: Thermal Infrared Imaging Evaluation and Hands Moving the Mask , 2020, International journal of environmental research and public health.

[10]  R. Ruslami,et al.  Type 2 Diabetes and its Impact on the Immune System , 2020, Current diabetes reviews.

[11]  R. Jayawardena,et al.  Enhancing immunity in viral infections, with special emphasis on COVID-19: A review , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[12]  S. Rudramurthy,et al.  A multicenter observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  H. Badali,et al.  Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. , 2019, The Lancet. Infectious diseases.

[14]  Kerstin Voelz,et al.  Innate and Adaptive Immunity to Mucorales , 2017, Journal of fungi.

[15]  S. Devereux,et al.  Outpatient management of steroid-induced hyperglycaemia and steroid-induced diabetes in people with lymphoproliferative disorders treated with intermittent high dose steroids , 2017, Journal of clinical & translational endocrinology.

[16]  A. Chughtai,et al.  A cluster randomised trial of cloth masks compared with medical masks in healthcare workers , 2015, BMJ Open.

[17]  A. Chakrabarti,et al.  Mucormycosis in India: unique features , 2014, Mycoses.

[18]  C. Lass‐Flörl,et al.  Mucormycosis--from the pathogens to the disease. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  A. Chakrabarti,et al.  Epidemiology of Mucormycosis in India , 2013, Current Fungal Infection Reports.

[20]  Jacques P. Brown,et al.  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy , 2013, Allergy, Asthma & Clinical Immunology.

[21]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[22]  J. Ribes,et al.  Zygomycetes in human disease. , 2000, Clinical microbiology reviews.

[23]  Y. Schneider,et al.  Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. , 1993, The Journal of clinical investigation.

[24]  R. Wolfe,et al.  The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  A Bryan,et al.  Diabetic ketoacidosis. , 2005, American family physician.